Non-invasive ventilation for acute exacerbation of COPD with very high PaCO2: A randomized controlled trial

Khilnani, Gopi C.; Saikia, Nripen; Banga, Amit; Sharma, Surendra K.
July 2010
Lung India;Jul-Sep2010, Vol. 27 Issue 3, p125
Academic Journal
Objective: To assess the role of non-invasive positive pressure ventilation (NIPPV) for management of Indian patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Materials and Methods: Forty patients (mean age 57.6 ± 10.8 years; M:F 31:9) with AECOPD with pH <7.35, admitted to the intensive care unit were included. Patients were randomized to receive NIPPV (N, n = 20) with conventional therapy or conventional therapy (C, n = 20) alone at admission. NIPPV was given through the nasal mask. Incidence of need of endotracheal intubation (ETI) was the primary efficacy variable. Hospital mortality, duration of hospital stay and change in clinical and blood gas parameters were the secondary outcome variables. Results: Mean pH at baseline for N and C groups were similar (7.23 ± 0.07) whereas PaCO2 was 85.4 ± 14.8 and 81.1 ± 11.6 mm of Hg, respectively. At one hour, patients in N group had greater improvement in pH (P = 0.017) as well as PaCO2 (P = 0.04) which corroborated with clinical improvement. Whereas need of ETI was reduced in patients who received NIPPV (3/20 vs 12/20, P = 0.003), in-hospital mortality was similar (3/20 and 2/20, P = NS). The mean duration of hospital stay was significantly shorter in N group (9.4 ± 4.3 days) as compared to C group (17.8 ± 2.6 days); P = 0.001. Conclusions: In patients with AECOPD, NIPPV leads to rapid improvement in blood gas parameters and reduces the need for ETI.


Related Articles

  • Clarifying aspects of noninvasive mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease. SCHREIBER, Annia; ESQUINAS, Antonio; ÇAKIR GÜRBÜZ, Özlem; ALAGÖZ, Ali; ULUS, Fatma; TUNÇ, Mehtap; ŞAHİN, Şaziye // Turkish Journal of Medical Sciences;2016, Vol. 46 Issue 1, p241 

    No abstract available.

  • High flow on the rise—pediatric perspectives on the FLORALI trial. Milési, Christophe; Baleine, Julien; Bouhellec, Julia le; Pons-Odena, Marti; Cambonie, Gilles // Journal of Thoracic Disease;Aug2015, Vol. 7 Issue 8, pE230 

    No abstract available.

  • Iron lung versus mask ventilation in acute exacerbation of COPD: a randomised crossover study. Corrado, A.; Gorini, M.; Melej, R.; Baglioni, S.; Mollica, C.; Villella, G.; Consigli, G.; Dottorini, M.; Bigioni, D.; Toschi, M.; Eslami, A. // Intensive Care Medicine;Apr2009, Vol. 35 Issue 4, p648 

    To compare iron lung (ILV) versus mask ventilation (NPPV) in the treatment of COPD patients with acute on chronic respiratory failure (ACRF). Randomised multicentre study. Respiratory intermediate intensive care units very skilled in ILV. A total of 141 patients met the inclusion criteria and...

  • Predictors of in-hospital mortality in patients with acute exacerbation of COPD requiring ventilation: a retrospective study. Wensen Pan; Jing Yu; Lili Zhang; Hongshen Yang; Yadong Yuan // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 11, p22093 

    Background: Previous studies sought to identify survival or outcome predictors in patients with chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation (MV), but their findings are inconsistent. This study aims to identify clinical predictors of in-hospital mortality among...

  • Clinical trials in COPD.  // Thorax;Dec2013 Supplement, Vol. 68 Issue S3, pA15 

    The article presents abstracts on topics related to chronic obstructive pulmonary diseases (COPD) including trials in pulmonary rehabilitation population, maintenance schedule impact in COPD pulmonary rehabilitation patients and COPD study results exacerbation with Prednisolone therapy.

  • COPD Exacerbations: The EXACT Tool.  // Internal Medicine Alert;Aug2011 Clinical Briefs in Primary, p16 

    The article reports on the use of the Exacerbations of Chronic Pulmonary Disease Tool (EXACT) to perform the first published formal analysis of chronic obstructive pulmonary disease exacerbations (COPE-e).

  • Number needed to treat in COPD: exacerbations versus pneumonias. Keene, Oliver N.; Anzueto, Antonio; Ferguson, Gary T.; Calverley, Peter M. A.; Suissa, Samy // Thorax;Sep2013, Vol. 68 Issue 9, p882 

    A letter to the editor is presented in response to the article "Number Needed to Treat in COPD: Exacerbations Versus Pneumonias" by S. Suissa and colleagues in the 2013 issue.

  • Inferring the quality of hospital treatment for COPD by mortality; caution is needed. Morgan, M. D. L. // Thorax;Oct2013, Vol. 68 Issue 10, p897 

    The article offers information on the treatment for Chronic obstructive pulmonary disease (COPD) by mortality and its impact on the quality of the hospitals. It mentions that in hospital care of COPD patients admitted with acute exacerbation would result in a reduction of mortality. It informs...

  • NIPPV Use Increases, But Mortality for Some Is Also Up.  // AARC Times;Jan2012, Vol. 36 Issue 1, p77 

    The article discusses a study which investigates the efficacy of noninvasive positive pressure ventilation (NIPPV) in the treatment of patient with chronic obstructive pulmonary disease (COPD).


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics